Filter
1616
Filtered Results: 1616
Text search:
World
Health
Organization
WHO,
Bangladesh
Featured
Recommendations
139
New Publications
449
Language
Document type
No document type
928
Studies & Reports
349
Guidelines
163
Manuals
74
Strategic & Response Plan
37
Training Material
25
Fact sheets
20
Situation Updates
9
Resource Platforms
6
Infographics
3
Brochures
1
Online Courses
1
Countries / Regions
Bangladesh
161
Global
118
Myanmar / Burma
68
Nepal
50
India
49
South–East Asia Region
43
Asia
41
Ethiopia
20
Uganda
17
Kenya
16
Syria
15
Indonesia
14
Nigeria
13
Philippines
13
Pakistan
13
Africa
11
Liberia
10
Thailand
10
Rwanda
10
Congo, Democratic Republic of
9
Afghanistan
9
South Africa
9
Zimbabwe
8
Zambia
8
Tanzania
8
Cambodia
8
Sierra Leone
7
Haiti
7
Malawi
7
Western and Central Europe
7
Ghana
6
Sri Lanka
6
Yemen
6
Latin America and the Carribbean
6
South Sudan
5
Ukraine
5
Burkina Faso
4
Senegal
4
Somalia
4
Jordan
4
China
4
Mozambique
4
Namibia
4
Colombia
4
Western Pacific Region
4
Eastern Europe
4
Russia
4
Vietnam
4
Lebanon
3
Sudan
3
Central African Republic
3
Brazil
3
East and Southern Africa
3
West and Central Africa
3
Venezuela
3
Guinea
2
Cameroon
2
Iraq
2
Papua New Guinea
2
Eswatini/ Swaziland
2
Bhutan
2
Albania
2
Laos
2
Georgia
2
Mali
1
Guinea-Bissau
1
Morocco
1
Saudi Arabia
1
Niger
1
Germany
1
Egypt
1
Chad
1
Benin
1
Peru
1
North Macedonia
1
Serbia
1
Honduras
1
Botswana
1
Greece
1
Libya
1
Madagascar
1
Mexico
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Other region
1
Paraguay
1
Palestine
1
North Korea
1
Italy
1
Mongolia
1
Timor Leste/ East Timor
1
Tajikistan
1
Moldova
1
Iran
1
Japan
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
413
Women & Child Health
163
Clinical Guidelines
142
Key Resources
131
Public Health
99
Capacity Building
42
Pharmacy & Technologies
17
Toolboxes
Disability
130
COVID-19
123
TB
109
Planetary Health
99
Mental Health
98
HIV
95
Global Health Education
58
Caregiver
50
NTDs
48
Rapid Response
37
Conflict
31
Natural Hazards
31
AMR
30
Refugee
29
Health Financing Toolbox
26
NCDs
24
Pharmacy
21
Cholera
17
Ebola
10
Polio
10
Zika
4
Specific Hazards
4
Social Ethics
3
Typhoon
2
Health Financing
1
For patients on NIPPV or HFNO with persistent hypoxaemia or respiratory distress:
• Check the equipment: inspect the exterior of the machine, the tubing (circuit), the mask for any sign of mechanical damage, confirm it fits securely without leak (if CPAP/BiPAP) and the filters are in place. Ensur...
Global tuberculosis report 2022
recommended
The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context...
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other <... workers can contribute to improving hypertension detection and management.
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicabl...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health...
The World Health Organization (WHO) and the global community of countries, partners, donors, tec...
Revised and expanded version of the Guidelines
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health ... (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting was attended by representatives from the health ministries of Albania, Georgia, Greece, Iran (Islamic Republic of), Iraq, Jordan, Lebanon, Morocco, Pakistan, Saudi Arabia, Sudan, Syrian Arab Republic and Tunisia. Representatives from Afghanistan, Algeria and Libya were unable to attend. The Secretariat comprised staff from WHO headquarters, WHO regional offices in the Eastern Mediterranean, Africa and Europe, WHO country offices in Iraq, Pakistan, Syrian Arab Republic and Yemen, and WHO temporary advisors from Spain and Tunisia.
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
coun...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
More than 700 000 people lose their life to suicide every year. A core foundation of suicide prevention is the timely registration and regular monitoring of suicide and self-harm. Surveillance data can be used to show important progress towards reaching global targets, such as reducing the suicide r...
Lymphatic filariasis (LF) is an avoidable, debilitating, disfiguring disease caused by infection with the filarial parasites Wuchereria bancrofti, Brugia malayi and B. timori. Globally, 51.4 million people are
estimated to be infected. Lymphoedema and hydrocoele are the visible, chronic clinical co...
La filariose lymphatique (FL) est une maladie évitable, incapacitante et défigurante, due à une infestation par des filaires parasites des espèces Wuchereria bancrofti, Brugia malayi et B. timori. On estime que 51,4 millions de personnes sont infectées dans le monde. Le lymphœdème et l’hydr...
Rabies remains an under-reported neglected zoonosis with a case-fatality rate of almost 100% in humans and animals. Dog-mediated human rabies causes tens of thousands of human deaths annually despite being 100% preventable. More than 95% of human cases are caused by the bite of a rabies-infected dog...
Traditional food markets play important economic, cultural, and social role and are sources of livelihood for millions of people in urban and rural areas. The manual Five keys for safer traditional food markets: risk mitigation in traditional food markets in the Asia-Pacific Region aims to support a...
В дорожной карте по борьбе с забытыми тропическими болезнями на 2021–2030 гг. («дорожная карта») определены глобальные цели и основные этапы в отношении борьбы с 20 бол...
Integrating neglected tropical diseases into global health and development: fourth WHO report on neglected tropical diseases evaluates the changing global public ... landscape; assesses progress towards the 2020 targets; and considers the possible core elements of a strategic vision to integrating neglected tropical diseases into the 2030 Agenda of the Sustainable Development Goals.
Advances have been made through expanded interventions delivered through five public health approaches: innovative and intensified disease management; preventive chemotherapy; vector ecology and management; veterinary public health services; and the provision of safe water, sanitation and hygiene. In 2015 alone nearly one billion people were treated for at least one disease and significant gains were achieved in relieving the symptoms and consequences of diseases for which effective tools are scarce; important reductions were achieved in the number of new cases of sleeping sickness, of visceral leishmaniasis in South-East Asia and also of Buruli ulcer.
The report also considers vector control strategies and discusses the importance of the draft WHO Global Vector Control Response 2017–2030. It argues that veterinary public health requires a multifaceted approach across the human–animal interface as well as a multisectoral programme of work to protect and improve the physical, mental and social well-being of humans, including veterinary, water, sanitation and hygiene.
Integration of activities and interventions into broader health systems is crucial, and despite challenges, has the potential to accelerate progress towards universal health coverage while advancing the 2030 Agenda.
In short, this report drives the message home that “no one must be left behind”.
The KMC implementation strategy targets a broad audience. These include policy-makers and programme managers at national, regional and local levels, government and nongovernmental organizations working in the area of maternal and newborn care, globa...
This document is an output of a WHO cross-programme initiative aiming to improve the prevention, diagnosis and management of anaemia and thereby accelerate reduction in its prevalence. It comes at an important time, midway through the era of the Sus...
